Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Progesterone receptor gene variants and risk of endometrial cancer
Author: O'Mara, T.
Fahey, P.
Ferguson, K.
Marquart, L.
Lambrechts, D.
Despierre, E.
Vergote, I.
Amant, F.
Hall, P.
Liu, J.
Czene, K.
Rebbeck, T.
WISE Study Group,
AOCS Management Group,
Ahmed, S.
Dunning, A.
Gregory, C.
Shah, M.
et al.
Citation: Carcinogenesis, 2011; 32(3):331-335
Publisher: Oxford University Press (OUP)
Issue Date: 2011
ISSN: 0143-3334
Statement of
Tracy A. O'Mara, Paul Fahey, Kaltin Ferguson, Louise Marquart, Diether Lambrechts, Evelyn Despierre, Ignace Vergote, Frederic Amant, Per Hall, Jianjun Liu, Kamila Czene, SASBAC, Timothy R. Rebbeck, WISE Study Group, AOCS Management Group, SEARCH, Shahana Ahmed, Alison M. Dunning, Catherine S. Gregory, Mitul Shah, ANECS, Penelope M. Webb and Amanda B. Spurdle
Abstract: Prolonged excessive estrogen exposure unopposed by progesterone is widely accepted to be a risk factor for endometrial cancer development. The physiological function of progesterone is dependent upon the presence of its receptor [progesterone receptor (PGR)] and several studies have reported single nucleotide polymorphisms (SNPs) in the PGR gene to be associated with endometrial cancer risk. We sought to confirm the associations with endometrial cancer risk previously reported for four different PGR polymorphisms. A maximum of 2888 endometrial cancer cases and 4483 female control subjects from up to three studies were genotyped for four PGR polymorphisms (rs1042838, rs10895068, rs11224561 and rs471767). Logistic regression with adjustment for age, study, ethnicity and body mass index was performed to calculate odds ratios (ORs) and associated 95% confidence intervals (CIs) and P-values. Of the four SNPs investigated, only rs11224561 in the 3′ region of the PGR gene was found to be significantly associated with endometrial cancer risk. The A allele of the rs11224561 SNP was associated with increased risk of endometrial cancer (OR per allele 1.31; 95% CI 1.12–1.53, P = 0.001, adjusted for age and study), an effect of the same magnitude and direction as reported previously. We have validated the endometrial cancer risk association with a tagSNP in the 3′ untranslated region of PGR previously reported in an Asian population. Replication studies will be required to refine the risk estimate and to establish if this, or a correlated SNP, is the underlying causative variant.
Keywords: SASBAC
WISE Study Group
AOCS Management Group
Endometrial Neoplasms
Genetic Predisposition to Disease
Receptors, Progesterone
DNA, Neoplasm
Odds Ratio
Risk Factors
Case-Control Studies
Polymerase Chain Reaction
Polymorphism, Single Nucleotide
Aged, 80 and over
Middle Aged
Young Adult
Description: Martin Oehler is a member of ANECS
Rights: © The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email:
DOI: 10.1093/carcin/bgq263
Grant ID:
Published version:
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.